Literature DB >> 22923402

Evidence of in vivo prophage induction during Clostridium difficile infection.

Mathieu Meessen-Pinard1, Ognjen Sekulovic, Louis-Charles Fortier.   

Abstract

Prophages contribute to the evolution and virulence of most bacterial pathogens, but their role in Clostridium difficile is unclear. Here we describe the isolation of four Myoviridae phages, ΦMMP01, ΦMMP02, ΦMMP03, and ΦMMP04, that were recovered as free viral particles in the filter-sterilized stool supernatants of patients suffering from C. difficile infection (CDI). Furthermore, identical prophages were found in the chromosomes of C. difficile isolated from the corresponding fecal samples. We therefore provide, for the first time, evidence of in vivo prophage induction during CDI. We completely sequenced the genomes of ΦMMP02 and ΦMMP04, and bioinformatics analyses did not reveal the presence of virulence factors but underlined the unique character of ΦMMP04. We also studied the mobility of ΦMMP02 and ΦMMP04 prophages in vitro. Both prophages were spontaneously induced, with 4 to 5 log PFU/ml detected in the culture supernatants of the corresponding lysogens. When lysogens were grown in the presence of subinhibitory concentrations of ciprofloxacin, moxifloxacin, levofloxacin, or mitomycin C, the phage titers further increased, reaching 8 to 9 log PFU/ml in the case of ΦMMP04. In summary, our study highlights the extensive genetic diversity and mobility of C. difficile prophages. Moreover, antibiotics known to represent risk factors for CDI, such as quinolones, can stimulate prophage mobility in vitro and probably in vivo as well, which underscores their potential impact on phage-mediated horizontal gene transfer events and the evolution of C. difficile.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22923402      PMCID: PMC3485732          DOI: 10.1128/AEM.02275-12

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  46 in total

1.  Observations on phage-typing of Clostridium difficile: preliminary evaluation of a phage panel.

Authors:  R Dei
Journal:  Eur J Epidemiol       Date:  1989-09       Impact factor: 8.082

2.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Authors:  Jacques Pépin; Nathalie Saheb; Marie-Andrée Coulombe; Marie-Eve Alary; Marie-Pier Corriveau; Simon Authier; Michel Leblanc; Geneviève Rivard; Mathieu Bettez; Valérie Primeau; Martin Nguyen; Claude-Emilie Jacob; Luc Lanthier
Journal:  Clin Infect Dis       Date:  2005-09-20       Impact factor: 9.079

3.  Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogens.

Authors:  Ognjen Sekulovic; Mathieu Meessen-Pinard; Louis-Charles Fortier
Journal:  J Bacteriol       Date:  2011-03-25       Impact factor: 3.490

4.  Two bacteriophages of Clostridium difficile.

Authors:  D E Mahony; P D Bell; K B Easterbrook
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

5.  Genomic organization and molecular characterization of Clostridium difficile bacteriophage PhiCD119.

Authors:  Revathi Govind; Joe A Fralick; Rial D Rolfe
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

6.  Prophage induction and expression of prophage-encoded virulence factors in group A Streptococcus serotype M3 strain MGAS315.

Authors:  David J Banks; Benfang Lei; James M Musser
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

7.  In vivo acquisition of prophage in Streptococcus pyogenes.

Authors:  Vincent A Fischetti
Journal:  Trends Microbiol       Date:  2007-05-31       Impact factor: 17.079

8.  Prophage spontaneous activation promotes DNA release enhancing biofilm formation in Streptococcus pneumoniae.

Authors:  Margarida Carrolo; Maria João Frias; Francisco Rodrigues Pinto; José Melo-Cristino; Mário Ramirez
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

9.  Characterizing RecA-independent induction of Shiga toxin2-encoding phages by EDTA treatment.

Authors:  Lejla Imamovic; Maite Muniesa
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

10.  Diverse temperate bacteriophage carriage in Clostridium difficile 027 strains.

Authors:  Janet Y Nale; Jinyu Shan; Peter T Hickenbotham; Warren N Fawley; Mark H Wilcox; Martha R J Clokie
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

View more
  40 in total

1.  Global transcriptional response of Clostridium difficile carrying the CD38 prophage.

Authors:  Ognjen Sekulovic; Louis-Charles Fortier
Journal:  Appl Environ Microbiol       Date:  2015-02       Impact factor: 4.792

Review 2.  Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens.

Authors:  Jennifer Venhorst; Jos M B M van der Vossen; Valeria Agamennone
Journal:  Front Microbiol       Date:  2022-06-13       Impact factor: 6.064

3.  Adaptive strategies and pathogenesis of Clostridium difficile from in vivo transcriptomics.

Authors:  Claire Janoir; Cécile Denève; Sylvie Bouttier; Frédéric Barbut; Sandra Hoys; Laxmee Caleechum; Diana Chapetón-Montes; Fátima C Pereira; Adriano O Henriques; Anne Collignon; Marc Monot; Bruno Dupuy
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

4.  Genetically diverse Clostridium difficile strains harboring abundant prophages in an estuarine environment.

Authors:  K R Hargreaves; H V Colvin; K V Patel; J J P Clokie; M R J Clokie
Journal:  Appl Environ Microbiol       Date:  2013-08-02       Impact factor: 4.792

Review 5.  Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.

Authors:  Justin D Glenn; Ellen M Mowry
Journal:  J Interferon Cytokine Res       Date:  2016-05-04       Impact factor: 2.607

6.  Characterization of temperate phages infecting Clostridium difficile isolates of human and animal origins.

Authors:  Ognjen Sekulovic; Julian R Garneau; Audrey Néron; Louis-Charles Fortier
Journal:  Appl Environ Microbiol       Date:  2014-02-14       Impact factor: 4.792

Review 7.  Clostridioides difficile phage biology and application.

Authors:  Joshua Heuler; Louis-Charles Fortier; Xingmin Sun
Journal:  FEMS Microbiol Rev       Date:  2021-09-08       Impact factor: 16.408

8.  As Clear as Mud? Determining the Diversity and Prevalence of Prophages in the Draft Genomes of Estuarine Isolates of Clostridium difficile.

Authors:  Katherine R Hargreaves; James R Otieno; Anisha Thanki; Matthew J Blades; Andrew D Millard; Hilary P Browne; Trevor D Lawley; Martha R J Clokie
Journal:  Genome Biol Evol       Date:  2015-05-27       Impact factor: 3.416

9.  A Taxonomic Review of Clostridium difficile Phages and Proposal of a Novel Genus, "Phimmp04likevirus".

Authors:  Katherine R Hargreaves; Martha R J Clokie
Journal:  Viruses       Date:  2015-05-21       Impact factor: 5.048

10.  Function of the CRISPR-Cas System of the Human Pathogen Clostridium difficile.

Authors:  Pierre Boudry; Ekaterina Semenova; Marc Monot; Kirill A Datsenko; Anna Lopatina; Ognjen Sekulovic; Maicol Ospina-Bedoya; Louis-Charles Fortier; Konstantin Severinov; Bruno Dupuy; Olga Soutourina
Journal:  MBio       Date:  2015-09-01       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.